This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Europe's premier partnering event
November 4–6, 2024 | Stockholm, SwedenNovember 12–13, 2024 | Digital Partnering

FoRx Therapeutics AG


FoRx Therapeutics is an incorporated privately held drug discovery company based in Basel, Switzerland. The company is active in oncology and focuses on drugging key molecular targets involved in the DNA replication stress pathway. This constitutes a novel and promising approach in the development of next-generation anti-cancer drugs. FoRx Therapeutics is backed by a syndicate of investors that include EQT Life Sciences, Novartis Venture Fund, Pfizer Ventures, M Ventures and Omega Funds.